Venrock Adviser, LLC
NEW YORK, NY · CIK 1615982 · 13F filing filed 2024-08-14
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$4.5bn
- Staff11 · 11 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds7 (1 hedge) · $4.5bn gross assets
- Form ADV · 2026-04-28SEC adviser record
- Legal entityVENROCK ADVISER, LLC (US)
$1.6bn
reported value
-25.3% vs Q1 2024
35positions
64.6%in top 10
6 new
6 added
3 reduced
9 sold out
vs Q1 2024
Holdings, Q2 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| APOGEE THERAPEUTICS INC COM | $334.2m21.28% | Unchanged |
| ENLIVEN THERAPEUTICS INC ELVN | $94.1m5.99% | Unchanged |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $92.4m5.88% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $87.3m5.56% | Unchanged |
| DYNE THERAPEUTICS INC DYN | $76.7m4.89% | Unchanged |
| MERUS N V MRUS | $74.7m4.76% | Reduced -527.0k |
| KALVISTA PHARMACEUTICALS INC KALV | $73.6m4.69% | Unchanged |
| PHARVARIS N V PHVS | $63.8m4.07% | Unchanged |
| SPYRE THERAPEUTICS INC SYRE | $63.1m4.02% | Added +513.7k |
| DIANTHUS THERAPEUTICS INC DNTH | $54.2m3.45% | Unchanged |
| VIRIDIAN THERAPEUTICS INC VRDN | $50.5m3.22% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $47.9m3.05% | Added +555.0k |
| APPLIED THERAPEUTICS INC APLT | $44.6m2.84% | Added +467.9k |
| ERASCA INC ERAS | $38.3m2.44% | New |
| ASTRIA THERAPEUTICS INC CATB | $32.8m2.09% | Unchanged |
| EDGEWISE THERAPEUTICS INC EWTX | $32.7m2.09% | Unchanged |
| ORIC PHARMACEUTICALS INC ORIC | $31.1m1.98% | Unchanged |
| PRAXIS PRECISION MEDICINES I PRAX | $29.2m1.86% | Added +5 |
| ENGENE HOLDINGS INC COM | $26.6m1.70% | Added +260.1k |
| CULLINAN THERAPEUTICS INC CGEM | $24.1m1.53% | New |
| TERNS PHARMACEUTICALS INC COM | $23.2m1.48% | Unchanged |
| MERSANA THERAPEUTICS INC COM | $22.8m1.45% | Unchanged |
| ZURA BIO LTD ZURA | $21.1m1.34% | New |
| TAYSHA GENE THERAPIES INC TSHA | $20.2m1.28% | Unchanged |
| ABIVAX SA ABVX | $17.8m1.13% | Unchanged |
| ARVINAS INC ARVN | $16.7m1.06% | Unchanged |
| AQUESTIVE THERAPEUTICS INC AQST | $14.4m0.92% | Unchanged |
| CENTURY THERAPEUTICS INC IPSC | $13.7m0.88% | Added +2.0m |
| CABALETTA BIO INC CABA | $11.7m0.75% | Unchanged |
| TREVI THERAPEUTICS INC TRVI | $10.2m0.65% | Reduced -38 |
| ADVERUM BIOTECHNOLOGIES INC ADVM | $10.1m0.64% | Reduced -89.4k |
| PERCEPTIVE CAP SOLUTIONS COR FRNM | $7.5m0.48% | New |
| TENAYA THERAPEUTICS INC TNYA | $4.8m0.31% | Unchanged |
| ARCA BIOPHARMA INC COM | $3.3m0.21% | New |
| CASI PHARMACEUTICALS INC CASIF | $614.3k0.04% | New |
Sold out since Q1 2024
| Security | Value then |
|---|---|
| HILLEVAX INC | $34.5m2.1m shares |
| CELCUITY INC CELC | $21.0m970.0k shares |
| IMMATICS N.V IMTX | $18.4m1.8m shares |
| LYRA THERAPEUTICS INC LYRA | $16.0m2.6m shares |
| CG ONCOLOGY INC CGON | $15.4m350.0k shares |
| MINERALYS THERAPEUTICS INC MLYS | $7.2m555.6k shares |
| ACELYRIN INC | $6.3m937.1k shares |
| EYEPOINT PHARMACEUTICALS INC EYPT | $5.2m250.0k shares |
| OLEMA PHARMACEUTICALS INC OLMA | $872.1k77.0k shares |